J.P. Morgan ER Reputation
How is the reputation at JPM ER relative to comps, GS/MS?
Trending Content
| +72 | Q&A - Buyside Equity Research Analyst/PM | 27 | 5d | |
| +31 | How the heck do you learn all of this stuff? | 5 | 2d | |
| +28 | Getting Frustrated | 10 | 2w | |
| +27 | My experience on the sell side | 20 | 1w | |
| +22 | What’s my next move? | 6 | 2w | |
| +20 | CS Major looking to switch and break into high finance - is it over for me? | 6 | 3w | |
| +20 | Vanderbilt vs. Notre Dame M.S. in Finance Equity Research placement | 10 | 3w | |
| +18 | Biotech ER vs IB | 16 | 2w | |
| +14 | Heard they don’t model at Oppenheimer | 10 | 1w | |
| +13 | ER time line and ways to break in help | 17 | 2w |
Career Resources
JPM is number 1 ranked for US ER research. BAML has been trying to dethrone JPM for that spot many years. MS is decent.
GS is not even a tier 1 conversation in ER, their only use is because they are on every single IPO.
Appreciate that. Thanks.
np
In terms of global research, BaML/JPM/UBS Tier 1. Citi not far behind. GS ER is probably amongst their weakest units. MS is decent but not tier 1.
Just painting a picture: I was looking at a name with 3 DISTINCT business segments, took a look at GS model. GS analyst slapped an EBITDA multiple on the consolidated EBITDA of the entire company and called that valuation.
GS ER is just as good as the other bulge brackets. No one cares about the actual valuation and the numbers they use. Corporate access and deals are what matters and GS is best in class alongside the other BBs.
Peopled hated this comment - please post and let me know where I'm wrong/your perspective.
I think your view should depend on your coverage and how you approach using sell-side.
I'm a L/S sector analyst, so I have street analysts that I think do better work. It will vary by sub-sector, and a lot of the time it's smaller banks that do the best work.
If I'm a generalist, I may view it as a "who's the best bank" rather than "who's the best analyst or team?"
FYI on rankings, I believe people are quoting institutional investor rankings which tend to be dominated by LO investors as it tends to be AUM-weighted. I haven't filled one out since I joined MM years ago.
Commodi voluptatem repellat tempora quia eum ut. Corrupti quia soluta ipsam porro. Eligendi cum itaque voluptates officiis placeat id. Aut sed culpa omnis quidem aut.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...